Level C· Early human research exploring benefitsProspective StudyPubMed

Enhanced lubricin secretion by human synovial mesenchymal stem cells compared to adipose mesenchymal stem cells.

Takakuwa T., Endo K., Ozeki N., Nakagawa Y., Koga H., Tomita M.

Prospective Study on Knee Osteoarthritis, Osteoarthritis, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Stem Cell Res Ther (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41299580
DOI
10.1186/s13287-025-04809-1

Abstract (original English)

Mesenchymal stem cell (MSC) therapy has emerged as a promising treatment option for knee osteoarthritis. Adipose MSCs are commonly used due to their easy accessibility; however, synovial MSCs have demonstrated a superior capacity for cartilage matrix synthesis. The mechanism underlying this difference in therapeutic efficacy may involve lubricin, a crucial glycoprotein that maintains joint lubrication and protects cartilage. Notably, lubricin levels decrease during the progression of osteoarthritis. The aim of this study was to compare extracellular lubricin secretion by human synovial MSCs versus adipose MSCs. We also analyzed potential correlations between synovial MSC lubricin secretion and synovial inflammation. Tissues for MSC isolation were obtained from 16 human donors with osteoarthritis who underwent total knee arthroplasty. Synovium was collected from the suprapatellar pouch on the femoral side, whereas adipose tissue was harvested from the subcutaneous layer of the knee skin incision. The synovial and adipose MSCs from each donor were cultured for 48 h (six replicate wells per donor), and lubricin concentrations in culture supernatants were measured using ELISA. For 11 donors, lubricin concentrations were measured directly, whereas the concentrations were normalized to cell number for the other 5 donors. MSC identity was assessed by flow cytometry and trilineage diff

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansMesenchymal Stem CellsAdipose TissueGlycoproteinsSynovial MembraneMaleFemaleMiddle AgedAgedCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research